According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM) is £0.47 B. In 2023 the company made a revenue of £0.31 B an increase over the revenue in the year 2022 that were of £62.34 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.